Showing results (981-990 of 1,041) with videos related to

Sort By:
Pageof 105
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
American Journal of Human Genetics|May 9, 2024
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regionsEileen O Dareng, Simon G Coetzee, Jonathan P Tyrer, et al.
Nature Communications|March 29, 2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerHui Shen, Brooke L Fridley, Honglin Song, et al.
British Journal of Cancer|February 20, 2014
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association ConsortiumD Agarwal, S Pineda, K Michailidou, et al.
Oncotarget|August 18, 2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancerShalaka S Hampras, Lara E Sucheston-Campbell, Rikki Cannioto, et al.
Nature Genetics|March 29, 2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPaul D P Pharoah, Ya-Yu Tsai, Susan J Ramus, et al.
Plos One|June 20, 2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskGanna Chornokur, Hui-Yi Lin, Jonathan P Tyrer, et al.
Nature Communications|September 23, 2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerKate Lawrenson, Qiyuan Li, Siddhartha Kar, et al.
Pageof 105